Mapping the growth hormone-Stat5b-IGF-I transcriptional circuit

Trends in Endocrinology and Metabolism

Volumn 23, Issue 4, 2012, Pages 186-193

  Rotwein, Peter ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; GROWTH HORMONE; HYPOPHYSIS HORMONE; INTERLEUKIN 6; JANUS KINASE 2; MESSENGER RNA; PROTEIN BCL 6; PROTEIN TYROSINE KINASE; RNA POLYMERASE II; SOMATOMEDIN C; STAT5B PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ABLATION THERAPY; BINDING SITE; BIOINFORMATICS; BODY GROWTH; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CELL MEMBRANE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONFORMATIONAL TRANSITION; CROHN DISEASE; DNA SEQUENCE; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GROWTH RETARDATION; HISTONE ACETYLATION; HORMONE BINDING; HUMAN; INFLAMMATORY DISEASE; NEGATIVE FEEDBACK; NONHUMAN; NUTRITIONAL DEFICIENCY; POSTNATAL DEVELOPMENT; POSTNATAL GROWTH; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CALORIE MALNUTRITION; PROTEIN PHOSPHORYLATION; REPORTER GENE; REVIEW; SIGNAL TRANSDUCTION;

EID: 84858752729     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2012.01.001     Document Type: Review

References (82)

1. Salmon W.J., Daughaday W. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J. Lab. Clin. Med. 1957, 49:825-836.
2. Daughaday W. A failed assay opened a new door in growth hormone research. Endocrinology 1992, 130:565-566.
3. Blundell T., Humbel R. Hormone families: pancreatic hormones and homologous growth factors. Nature 1980, 287:781-787.
4. D'ercole A.J., et al. Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc. Natl. Acad. Sci. U.S.A. 1984, 81:935-939.
5. Murphy L.J., et al. Identification, characterization, and regulation of a rat complementary deoxyribonucleic acid which encodes insulin-like growth factor-I. Endocrinology 1987, 121:684-691.
6. Roberts C.J., et al. Molecular cloning of rat insulin-like growth factor I complementary deoxyribonucleic acids: differential messenger ribonucleic acid processing and regulation by growth hormone in extrahepatic tissues. Mol. Endocrinol. 1987, 1:243-248.
7. Norstedt G., Moller C. Growth hormone induction of insulin-like growth factor I messenger RNA in primary cultures of rat liver cells. J. Endocrinol. 1987, 115:135-139.
8. Bichell D.P., et al. Growth hormone rapidly activates insulin-like growth factor I gene transcription in vivo. Mol. Endocrinol. 1992, 6:1899-1908.
9. Lanning N., Carter-Su C. Recent advances in growth hormone signaling. Rev. Endocr. Metab. Disord. 2006, 7:225-235.
10. Waters M.J., et al. New insights into growth hormone action. J. Mol. Endocrinol. 2006, 36:1-7.
11. Brooks A., Waters M. The growth hormone receptor: mechanism of activation and clinical implications. Nat. Rev. Endocrinol. 2010, 6:515-525.
12. Hennighausen L., Robinson G.W. Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B. Genes Dev. 2008, 22:711-721.
13. Hwa V., et al. STAT5b deficiency: lessons from STAT5b gene mutations. Best Pract. Res. Clin. Endocrinol. Metab. 2011, 25:61-75.
14. Hosui A., Hennighausen L. Genomic dissection of the cytokine-controlled STAT5 signaling network in liver. Physiol. Genomics 2008, 34:135-143.
15. Yoo K.H., et al. Context-specific growth hormone signaling through the transcription factor STAT5: implications for the etiology of hepatosteatosis and hepatocellular carcinoma. Genes Cancer 2011, 2:3-9.
16. Levy D.E., Darnell J.J. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 2002, 3:651-662.
17. Udy G.B., et al. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:7239-7244.
18. Teglund S., et al. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 1998, 93:841-850.
19. Rowland J., et al. In vivo analysis of growth hormone receptor signaling domains and their associated transcripts. Mol. Cell. Biol. 2005, 25:66-77.
20. Barclay J., et al. In vivo targeting of the growth hormone receptor (GHR) Box1 sequence demonstrates that the GHR does not signal exclusively through JAK2. Mol. Endocrinol. 2010, 24:204-217.
21. Rotwein, P. (1999) Molecular biology of IGF-I and IGF-II. In Contemporary Endocrinology: The IGF System (Rosenfeld, R. and Roberts, C.J., eds), pp. 19-35, Humana Press.
22. Hall L.J., et al. Functional analysis of the rat insulin-like growth factor I gene and identification of an IGF-I gene promoter. DNA Cell Biol. 1992, 11:301-313.
23. Barton E. The ABCs of IGF-I isoforms: impact on muscle hypertrophy and implications for repair. Appl. Physiol. Nutr. Metab. 2006, 31:791-797.
24. Hepler J.E., et al. Different half-lives of insulin-like growth factor I mRNAs that differ in length of 3' untranslated sequence. Endocrinology 1990, 127:1550-1552.
25. Bichell D.P., et al. Prostaglandin E2 rapidly stimulates insulin-like growth factor-I gene expression in primary rat osteoblast cultures: evidence for transcriptional control. Endocrinology 1993, 133:1020-1028.
26. Matheny R.J., et al. Minireview: mechano-growth factor: a putative product of IGF-I gene expression involved in tissue repair and regeneration. Endocrinology 2010, 151:865-875.
27. Chia D., et al. Distinct alterations in chromatin organization of the two IGF-I promoters precede growth hormone-induced activation of IGF-I gene transcription. Mol. Endocrinol. 2010, 24:779-789.
28. Woelfle J., et al. Acute control of insulin-like growth factor-I gene transcription by growth hormone through Stat5b. J. Biol. Chem. 2003, 278:22696-22702.
29. Chia D.J., Rotwein P. Defining the epigenetic actions of growth hormone: acute chromatin changes accompany GH-activated gene transcription. Mol. Endocrinol. 2010, 24:2038-2049.
30. Woelfle J., et al. Mechanisms of growth hormone (GH) action. Identification of conserved Stat5 binding sites that mediate GH-induced insulin-like growth factor-I gene activation. J. Biol. Chem. 2003, 278:51261-51266.
31. Wang Y., Jiang H. Identification of a distal STAT5-binding DNA region that may mediate growth hormone regulation of insulin-like growth factor-I gene expression. J. Biol. Chem. 2005, 280:10955-10963.
32. Chia D.J., et al. Characterization of distinct Stat5b binding sites that mediate growth hormone-stimulated IGF-I gene transcription. J. Biol. Chem. 2006, 281:3190-3197.
33. Eleswarapu S., et al. Growth hormone regulation of insulin-like growth factor-I gene expression may be mediated by multiple distal signal transducer and activator of transcription 5 binding sites. Endocrinology 2008, 149:2230-2240.
34. Laz E.V., et al. Dynamic in vivo binding of STAT5 to growth hormone-regulated genes in intact rat liver. Sex-specific binding at low- but not high-affinity STAT5 sites. Mol. Endocrinol. 2009, 23:1242-1254.
35. Chia D., et al. Dispersed chromosomal Stat5b-binding elements mediate growth hormone-activated insulin-like growth factor-I gene transcription. J. Biol. Chem. 2010, 285:17636-17647.
36. Ehret G.B., et al. DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites. J. Biol. Chem. 2001, 276:6675-6688.
37. Soldaini E., et al. DNA binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites. Mol. Cell. Biol. 2000, 20:389-401.
38. Jothi R., et al. Genome-wide identification of in vivo protein-DNA binding sites from ChIP-Seq data. Nucleic Acids Res. 2008, 36:5221-5231.
39. Ling G., et al. Unbiased, genome-wide in vivo mapping of transcriptional regulatory elements reveals sex differences in chromatin structure associated with sex-specific liver gene expression. Mol. Cell. Biol. 2010, 30:5531-5544.
40. Rando O.J., Chang H.Y. Genome-wide views of chromatin structure. Annu. Rev. Biochem. 2009, 78:245-271.
41. Heintzman N.D., et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 2007, 39:311-318.
42. Heintzman N., et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 2009, 459:108-112.
43. Robertson A., et al. Genome-wide relationship between histone H3 lysine 4 mono- and tri-methylation and transcription factor binding. Genome Res. 2008, 18:1906-1917.
44. Robertson G., et al. Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat. Methods 2007, 4:651-657.
45. Conaway R.C., et al. The mammalian Mediator complex and its role in transcriptional regulation. Trends Biochem. Sci. 2005, 30:250-255.
46. Levine M. Transcriptional enhancers in animal development and evolution. Curr. Biol. 2010, 20:R754-R763.
47. Bulger M., Groudine M. Functional and mechanistic diversity of distal transcription enhancers. Cell 2011, 144:327-339.
48. Dekker J., et al. Capturing chromosome conformation. Science 2002, 295:1306-1311.
49. Fullwood M., Ruan Y. ChIP-based methods for the identification of long-range chromatin interactions. J. Cell. Biochem. 2009, 107:30-39.
50. Chang C.C., et al. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:6947-6952.
51. Seyfert V.L., et al. Transcriptional repression by the proto-oncogene BCL-6. Oncogene 1996, 12:2331-2342.
52. Meyer R.D., et al. Male-specific hepatic Bcl6: growth hormone-induced block of transcription elongation in females and binding to target genes inversely coordinated with STAT5. Mol. Endocrinol. 2009, 11:1914-1926.
53. Chen Y., et al. Computational and functional analysis of growth hormone (GH)-regulated genes identifies the transcriptional repressor B-cell lymphoma 6 (Bc16) as a participant in GH-regulated transcription. Endocrinology 2009, 150:3645-3654.
54. Jorgensen J., et al. Effects of GH in human muscle and fat. Pediatr. Nephrol. 2010, 25:705-709.
55. Vijayakumar A., et al. Biological effects of growth hormone on carbohydrate and lipid metabolism. Growth Horm. IGF Res. 2010, 20:1-7.
56. Baik M., et al. Growth hormone-STAT5 regulation of growth, hepatocellular carcinoma, and liver metabolism. Ann. N. Y. Acad. Sci. 2011, 1229:29-37.
57. Berryman D., et al. Growth hormone and adipose tissue: beyond the adipocyte. Growth Horm. IGF Res. 2011, 21:113-123.
58. Thissen J., et al. Regulation of insulin-like growth factor-I in starvation and injury. Nutr. Rev. 1999, 57:167-176.
59. Lang C., et al. Cytokine inhibition of JAK-STAT signaling: a new mechanism of growth hormone resistance. Pediatr. Nephrol. 2005, 20:306-312.
60. Walters T.D., Griffiths A. Mechanisms of growth impairment in pediatric Crohn's disease. Nat. Rev. Gastroenterol. Hepatol. 2009, 6:513-523.
61. Mauras N. Can growth hormone counteract the catabolic effects of steroids?. Horm. Res. 2009, 72(Suppl. 1):48-54.
62. Beauloye V., et al. Impairment of liver GH receptor signaling by fasting. Endocrinology 2002, 143:792-800.
63. Straus D.S. Nutritional regulation of hormones and growth factors that control mammalian growth. FASEB J. 1994, 8:6-12.
64. Kliewer S., Mangelsdorf D. Fibroblast growth factor 21: from pharmacology to physiology. Am. J. Clin. Nutr. 2010, 91:254S-257S.
65. Itoh N. Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease. Cell Tissue Res. 2010, 342:1-11.
66. Inagaki T., et al. Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metab. 2008, 8:77-83.
67. Chen W., et al. Growth hormone induces hepatic production of fibroblast growth factor 21 through a mechanism dependent on lipolysis in adipocytes. J. Biol. Chem. 2011, 286:34559-34566.
68. Ahmed T., et al. Tumor necrosis factor inhibits growth hormone-mediated gene expression in hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 291:G35-G44.
69. Mcewan I.J. Nuclear receptors: one big family. Methods Mol. Biol. 2009, 505:3-18.
70. Heitzer M., et al. Glucocorticoid receptor physiology. Rev. Endocr. Metab. Disord. 2007, 8:321-330.
71. Engblom D., et al. Direct glucocorticoid receptor-Stat5 interaction in hepatocytes controls body size and maturation-related gene expression. Genes Dev. 2007, 21:1157-1162.
72. Tronche F., et al. Glucocorticoid receptor function in hepatocytes is essential to promote postnatal body growth. Genes Dev. 2004, 18:492-497.
73. Thomas C., Gustafsson J. The different roles of ER subtypes in cancer biology and therapy. Nat. Rev. Cancer 2011, 11:597-608.
74. Nilsson S., Gustafsson J. Estrogen receptors: therapies targeted to receptor subtypes. Clin. Pharmacol. Ther. 2011, 89:44-55.
75. Hewitt S., et al. Estrogen-mediated regulation of Igf1 transcription and uterine growth involves direct binding of estrogen receptor alpha to estrogen-responsive elements. J. Biol. Chem. 2010, 285:2676-2685.
76. Feng X., Mcdonald J. Disorders of bone remodeling. Annu. Rev. Pathol. 2011, 6:121-145.
77. Zaidi M. Skeletal remodeling in health and disease. Nat. Med. 2007, 13:791-801.
78. Kleinberg D., Barcellos-Hoff M.H. The pivotal role of insulin-like growth factor I in normal mammary development. Endocrinol. Metab. Clin. North Am. 2011, 40:461-471.
79. Rosenfeld R., Hwa V. The growth hormone cascade and its role in mammalian growth. Horm. Res. 2009, 71(Suppl. 2):36-40.
80. Berryman D., et al. Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models. Growth Horm. IGF Res. 2008, 18:455-471.
81. Fontana L., et al. Extending healthy life span - from yeast to humans. Science 2010, 328:321-326.
82. Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat. Rev. Cancer 2008, 8:915-928.